Key statistics
As of last trade, Fibrobiologics Inc (FBLG:NMQ) traded at 3.39, 214.36% above the 52 week low of 1.08 set on Aug 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.43 |
---|---|
High | 3.54 |
Low | 3.30 |
Bid | 3.38 |
Offer | 3.44 |
Previous close | 3.24 |
Average volume | 1.45m |
---|---|
Shares outstanding | 35.16m |
Free float | 25.22m |
P/E (TTM) | -- |
Market cap | 113.92m USD |
EPS (TTM) | -0.939 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 16:06 BST.
More ▼
- FibroBiologics Engages Southern Star Research as CRO in Australia
- FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
- FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
- FibroBiologics Files 2024 Second Quarter Report
- FibroBiologics to Present at JonesTrading Healthcare Summit 2024
- FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
- FibroBiologics Set to Join Russell 2000® Index
- FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
- FibroBiologics Announces 2024 Annual Meeting of Stockholders
More ▼